sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Androst-1-en-3-one, 1-methyl-17-[(1-oxoheptyl)oxy]-, (5α,17β)-

Androst-1-en-3-one, 1-methyl-17-[(1-oxoheptyl)oxy]-, (5α,17β)-

CAS No.:
303-42-4
Catalog Number:
AG002ZJV
Molecular Formula:
C27H42O3
Molecular Weight:
414.6206
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
5mg
≥98%
1 week
United States
$161
- +
10mg
≥98%
1 week
United States
$230
- +
50mg
≥98%
1 week
United States
$751
- +
Product Description
Catalog Number:
AG002ZJV
Chemical Name:
Androst-1-en-3-one, 1-methyl-17-[(1-oxoheptyl)oxy]-, (5α,17β)-
CAS Number:
303-42-4
Molecular Formula:
C27H42O3
Molecular Weight:
414.6206
MDL Number:
MFCD00864190
IUPAC Name:
[(5S,8R,9S,10S,13S,14S,17S)-1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
InChI:
InChI=1S/C27H42O3/c1-5-6-7-8-9-25(29)30-24-13-12-22-21-11-10-19-17-20(28)16-18(2)27(19,4)23(21)14-15-26(22,24)3/h16,19,21-24H,5-15,17H2,1-4H3/t19-,21-,22-,23-,24-,26-,27-/m0/s1
InChI Key:
TXUICONDJPYNPY-FRXWOFFRSA-N
SMILES:
CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)C(=CC(=O)C2)C
EC Number:
206-141-6
UNII:
0SPD480WFH
NSC Number:
64967
Properties
Complexity:
709  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
7  
Defined Bond Stereocenter Count:
0
Exact Mass:
414.313g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
414.63g/mol
Monoisotopic Mass:
414.313g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
43.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
6.9  
Literature
Title Journal
Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform. Toxicology 20170615
Analysis of methyloxime derivatives of intact esters of testosterone and boldenone in equine plasma using ultra high performance liquid chromatography tandem mass spectrometry. Drug testing and analysis 20110401
Change in thigh muscle cross-sectional area through administration of an anabolic steroid during routine stroke rehabilitation in hemiplegic patients. American journal of physical medicine & rehabilitation 20110201
Addition of an anabolic steroid to strength training promotes muscle strength in the nonparetic lower limb of poststroke hemiplegia patients. The International journal of neuroscience 20100901
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. British journal of sports medicine 20050501
Properties